P C Atkins
Overview
Explore the profile of P C Atkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Zweiman B, Valenzano M, Atkins P
Immunopharmacology
. 1998 Oct;
39(3):225-34.
PMID: 9754908
Background: Sera of about 30% of patients with chronic idiopathic urticaria (CIU) have increased histamine releasing activity (HRA+) on normal basophils. It is not known whether other CIU sera would...
3.
Zweiman B, von Allmen C, Schwartz L, Atkins P
J Allergy Clin Immunol
. 1998 Jul;
102(1):94-8.
PMID: 9679852
Background: Previous studies have suggested altered responses to repeat skin tests in the sites of IgE-mediated late-phase reactions (LPRs) induced within the previous 48 hours. To explore the possible modulation...
4.
Zweiman B, Atkins P, Moskovitz A, von Allmen C, Ciliberti M, Grossman S
J Allergy Clin Immunol
. 1997 Oct;
100(3):341-7.
PMID: 9314346
Background: In some previous studies, the antihistamine cetirizine has inhibited both developing (at 6 hours) and established (at 24 hours) gross late-phase skin reactions (LPR) to pollen antigens, possibly relevant...
5.
Atkins P, Zweiman B, Moskovitz A, von Allmen C, Ciliberti M
J Allergy Clin Immunol
. 1997 Jun;
99(6 Pt 1):806-11.
PMID: 9215249
Background: Events in developing cutaneous late-phase allergic reactions can be characterized by a combination of skin chamber and biopsy approaches. In some previous studies, cetirizine reportedly inhibited mediator release and/or...
6.
Zweiman B, Valenzano M, Atkins P, Tanus T, Getsy J
J Allergy Clin Immunol
. 1996 Jul;
98(1):89-98.
PMID: 8765822
Background: The serum histamine-releasing activity (HRA) found in a sizable percentage of patients with chronic idiopathic urticaria (CIU) has been partially characterized. However, the variable effect of individual HRA+ sera...
7.
Tanus T, Atkins P, Zweiman B
Clin Diagn Lab Immunol
. 1996 Jan;
3(1):135-7.
PMID: 8770518
We found increased serum histamine-releasing activity (HRA) in 27% of patients with chronic idiopathic urticaria. Patterns of clinical manifestations were similar in those with and without serum HRA, including responses...
8.
Atkins P, Zweiman B, Littman B, Presti C, von Allmen C, Moskovitz A, et al.
J Allergy Clin Immunol
. 1995 Mar;
95(3):742-7.
PMID: 7897158
Background: There have been conflicting reports about the effects of inhibition of arachidonic acid metabolism on early- and late-phase cutaneous reactions. We re-examined this question with a unique nonsteroidal antiinflammatory...
9.
Tanus T, Mines D, Atkins P, Levinson A
Ann Emerg Med
. 1994 Jul;
24(1):104-7.
PMID: 8010539
Anaphylaxis is a life-threatening disease that characteristically presents with multiple arrays of dermatologic, respiratory, cardiovascular, and gastrointestinal derangements, in general, suddenly after exposure to an allergen. It can, however, occur...
10.
Tanus T, Levinson A, Atkins P, Zweiman B
J Intern Med
. 1993 Nov;
234(5):525-7.
PMID: 8228799
Common variable immunodeficiency (CVI) is a heterogenous disorder with hypogammaglobulinaemia and multiple bacterial infections primarily involving the sinopulmonary tract. CVI patients have been known to have an increased tendency to...